About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Breast CancerHouston

Breast Cancer Clinical Trials in Houston

Find 1,199 clinical trials for breast cancer near Houston, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 961-980 of 1,199 trials

CompletedALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DThis was a four-arm (parallel group) randomized, open-label, multicenter Phase 3 study to investigate the use of a combination of Lapatinib and Trastuzumab, a sequence of…NCT00490139·Mobile, Alabama and 923 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.NCT06590857·Phoenix, Arizona and 30 others

Active not recruitingAbemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerThis study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…NCT05169567·Phoenix, Arizona and 137 others

Active not recruitingA Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerA phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of ribociclib with Endocrine Therapy (ET) as an adjuvant treatment in women and men with…NCT03701334·Birmingham, Alabama and 386 others

CompletedAn Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast CancerThe purpose of this study is to determine if ganetespib (STA-9090) is effective in the treatment of patients with HER2+ or triple negative breast cancer who have not received…NCT01677455·Birmingham, Alabama and 24 others

Active not recruitingDecision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerThis trial studies how well a decision aid website works in helping to make decisions about fertility in participants with cancer.NCT03141437·Houston, Texas

RecruitingStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesThis study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer…NCT05417594·La Jolla, California and 31 others

TerminatedPilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast CancerThis is a pilot "window of opportunity" clinical study in patients with operable breast cancer investigating use of reparixin as single agent in the time period between clinical…NCT01861054·Indianapolis, Indiana and 8 others

CompletedA Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast CancerThis study will determine whether the investigational drug dasatinib is effective in treatment of women with progressive advanced triple-negative breast cancer.NCT00371254·San Francisco, California and 9 others

CompletedA Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateThe purpose of this study is to collect follow-up safety data from participants in completed abiraterone acetate studies for a maximum duration of 9 years.NCT01517802·Aurora, Colorado and 21 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

TerminatedPhase II Neoadjuvant in Inflammatory Breast CancerThe goal of this clinical research study is to learn how well lapatinib taken alone, followed by taking lapatinib with paclitaxel, and then taking lapatinib with 5-fluorouracil…NCT00756470·Houston, Texas

Active not recruitingAdditional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal TherapyThis phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take…NCT04379570·Birmingham, Alabama and 525 others

CompletedA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerTo demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2…NCT01421472·Birmingham, Alabama and 37 others

TerminatedAromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT StudyThis phase II trial studies how well letrozole, anastrozole, or fulvestrant work when given together with ribociclib, palbociclib, and/or abemaciclib in treating patients with…NCT04256941·Houston, Texas

CompletedInjection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast CancerRATIONALE: Diagnostic procedures, such as lymphoscintigraphy using an injection under the nipple or near the tumor, may help doctors find out how far the disease has spread.NCT00438477·Houston, Texas

TerminatedA Study Of PF-06647263 In Patients With Advanced Solid TumorsTo assess the safety and tolerability at increasing dose levels of PF-06647263 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select…NCT02078752·Boston, Massachusetts and 9 others

Active not recruitingSecondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of TucatinibPatients with advanced HER2+ breast cancer on maintenance trastuzumab/pertuzumab or T-DM1 with 1st or 2nd intracranial disease event (brain metastases) and stable extracranial…NCT05323955·San Francisco, California and 7 others

TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesThis phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain…NCT04789668·Houston, Texas

TerminatedStudy of ORM-5029 in Subjects With HER2-Expressing Advanced Solid TumorsThis is a Phase 1 first-in-human study of ORM-5029 in participants with HER2-expressing advanced solid tumors.NCT05511844·Birmingham, Alabama and 10 others

PreviousPage 49 of 60Next

Other Conditions in Houston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma

Clareo Health | Breast Cancer Clinical Trials in Houston | 1,199 Studies